Felisa sells XON 31.44: In addition to developing oral BDP as a MCM, the company is also pursuing oral BDP as a treatment for GI inflammation in pediatric Crohn's disease and acute radiation enteritis.

These risks and uncertainties include risks and uncertainties related to market conditions and the satisfaction of customary closing conditions related to the offering. Griffin Securities and Wunderlich Securities are acting as co-managers for the offering. JMP Securities LLC is acting as sole book-running manager and Stifel is acting as lead manager for the offering. The offering is expected to close on August 26, 2015, subject to customary closing conditions. All of the shares in the offering will be sold by Intrexon.


Margeret:
A New York City bill to improve the nutrition of children's fast food meals could reduce the average calories and improve the nutrition of these meals, a new study claims.

Giselle:
On college campuses nationwide, daily cigarette smoking appears to be in steep decline while the rate of smoking pot each day climbs, well, higher.

Reda:
The U.S. smoking rate continues to decline, with just over 15 percent of adults reporting they're current smokers, a new government survey reveals.

Theresa:
Intrexon has granted the underwriters a 30-day option to purchase up to an additional 731,707 shares of common stock offered in the public offering.

Dung:
JMP Securities LLC is acting as sole book-running manager and Stifel is acting as lead manager for the offering.

Jacelyn:
These risks and uncertainties include risks and uncertainties related to market conditions and the satisfaction of customary closing conditions related to the proposed offering.

Georgene:
Intrexon intends to use the net proceeds from this offering for general corporate purposes as well as for strategic acquisitions or investments.

Lera:
Intrexon intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of the common stock offered in the public offering.

Erin:
On average, equities research analysts anticipate that Intrexon Corp will post ($0.09) EPS for the current fiscal year.

Abby:
Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company.

Intrexon Corp (NYSE:XON)
//stockhand.net/us/?q=nyse%3Axon&id=373750